[Skip to Content]
[Skip to Content Landing]
Views 1,409
Citations 0
Research Letter
September 16, 2019

Public Knowledge of Human Papillomavirus and Receipt of Vaccination Recommendations

Author Affiliations
  • 1Center for Health Services Research, Department of Management, Policy and Community Health, UTHealth School of Public Health, Houston, Texas
  • 2Department of Pediatrics, Baylor College of Medicine, Houston, Texas
  • 3Massachusetts General Hospital Institute for Technology Assessment, Harvard Medical School, Boston
  • 4Clinical Cancer Center/Center for AIDS Intervention Research, Medical College of Wisconsin, Milwaukee
  • 5Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston
  • 6Center for Healthcare Data, Department of Management, Policy and Community Health, UTHealth School of Public Health, Houston, Texas
JAMA Pediatr. Published online September 16, 2019. doi:10.1001/jamapediatrics.2019.3105

Human papillomavirus (HPV) vaccination coverage (48.6% in 2017) in the United States remains far below the Healthy People 2020 goal of 80%, and a 10% difference in coverage between boys (44.3%) and girls (53.1%) has been reported.1 Knowledge of HPV among vaccine-eligible individuals and their parents is critical to vaccine uptake. Furthermore, the recommendation to receive an HPV vaccine from health care professionals can help parents in their decision-making to vaccinate children.2 Therefore, we evaluated the national-level estimates of (1) HPV knowledge and (2) receipt of HPV vaccine recommendation from a health care professional.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×